北美医药市场中的环糊精 - 行业趋势和 2030 年预测

北美环糊精在医药市场的分析和规模

最近，预计在 2023-2030 年的预测期内，制药市场中的环糊精将大幅增长。环糊精广泛用于制造化妆品和个人护理用品，例如面膜、面霜和乳液等，预计未来几年将增加市场扩张。与此同时，增强免疫力的膳食补充剂在全球范围内越来越受欢迎，这可能会在预测期内增加市场扩张。

Data Bridge Market Research 分析了 2023-2030 年预测期内制药市场环糊精的增长率。在上述预测期内，制药市场环糊精的预期复合年增长率约为 3.4%。2022 年市场价值为 5370 万美元，到 2030 年将增长至 7020 万美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

北美环糊精在医药市场的分布及细分

Market Definition

Cyclodextrins are the kind of complex cyclic sugar which is made up of a macrocyclic ring of glucose subunits that is linked together by alpha-1,4 glycosidic linkages. Cyclodextrin is formed when a starch is decomposed enzymatically into simple molecules. Cyclodextrin is widely used in the pharmaceutical and chemical industries in the form of solvent component in medication delivery. Cyclodextrin is widely used to increase drug water solubility, stability, and bioavailability by encapsulating hydrophobic medicinal molecules in biological systems.   

North America Cyclodextrins in Pharma Market Dynamics

Drivers

• Increasing Consumption of Dietary Supplements

The increasing consumption of dietary supplements is projected to increase the market's growth. Excipients such as cyclodextrin are used in pharmaceutical and nutraceutical formulations. Also because of COVID-19 pandemic, physicians have prescribed a wide variety of antiviral therapeutics to patients to help them fight the virus early on. The increasing use of these medications has increased the cyclodextrin consumption, boosting market growth throughout the forecast period 2023-2030.

• Increasing investment for healthcare infrastructure

Another factor that is boosting the growth of the cyclodextrins in pharma market is the increasing healthcare expenditure that helps in improving its infrastructure. Additionally, numeorus government organizations aim to develop the healthcare infrastructure by growing their funding that will influence the dynamics of cyclodextrins in the pharma market. Moreover, rising initiatives by private and public organizations to increase awareness will increase the demand for cyclodextrins in the pharma market. Furthermore, the huge drift of consumer behavior towards health and the rising use of cyclodextrins in renal diseases will also increase the cyclodextrins in pharma market growth.

Opportunities

• Huge Application in Drug Solubility And Dissolution

Cyclodextrins have a wide application in drug solubility and dissolution which are anticipated to dominate the market because of the presence of cyclodextrins for many administrations, such as oral, gastrointestinal, top-of-the-line drugs to increase drug efficacy. Thus, this boosts the market growth.   

• Rising Adoption of Direct Tender Segment

The direct tender channel is majorly increasing the market growth since the drugs are used for the cyclodextrins in pharma that can be obtained through direct tender on reasonable price and the patients receive treatment for prolonged period of time. Therefore, this factor enhances the market growth.

Restraints/Challenges

• High Cost of Treatment

There are numerous treatment methods which requires surgery and high-end medications that demand huge cost. These treatment processes cannot be retrieved by the lower economic groups. Therefore, this factor impedes the market growth since the treatment options are not feasible for all the economic groups.

• Lack of Reimbursement Policies

There is a lack of reimbursement for cyclodextrins in pharma, which are expected to restrict the market growth. Both public and private payers do not compensate majority of the treatment services. The high cost of such services vary much and there cannot be any standardization. Therefore, this factor hampers the market growth.

This cyclodextrins in pharma market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cyclodextrins in pharma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

North America Cyclodextrins in Pharma Market Scope

医药市场中的环糊精根据类型、结构、性质、形式、应用、治疗领域和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

• Β 环糊精
• 2-羟丙基-β-环糊精
• α-环糊精
• γ-环糊精
• 随机甲基化β-环糊精
• 磺丁基醚β-环糊精
• 2-羟丙基-γ-环糊精

结构

• 环糊精结合物
• 粘膜粘附药物载体
• 环糊精缔合物
• 两亲性环糊精
• 其他的

自然

• 亲水性
• 疏水性

形式

• 坚硬的
• 液体

应用

• 药物溶解度和溶解
• 药物生物利用度
• 药品安全
• 药物稳定性
• 其他的

治疗领域

• 疼痛管理
• 心血管疾病
• 行为障碍
• 癌症治疗
• 类风湿关节炎
• 癫痫
• 尼曼匹克病 C 型（NPC）
• 其他的

分销渠道

• 直接招标
• 零售销售
• 其他的

医药市场中的环糊精区域分析/见解

对制药市场中的环糊精进行了分析，并根据上述类型、结构、性质、形式、应用、治疗领域和分销渠道提供了市场规模洞察和趋势。

医药市场环糊精报告涉及的主要国家 是北美的美国、加拿大和墨西哥。

美国凭借其众多的公司数量、研发能力以及药理学领域新型环糊精先导药物的广泛存在，在北美设备市场占据领先地位。  

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。 

竞争格局和北美环糊精在医药市场的份额分析

制药市场环糊精竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对制药市场环糊精的关注有关

制药市场中环糊精的主要参与者包括：

• Cambrex 公司 (美国)
• 开曼化学 (美国)
• Wellona Pharma（印度）
• 瓦克化学股份有限公司（德国）
• 托科医药有限公司 (中国)
• 罗盖特兄弟公司（法国）
• Midas Pharma GmbH（德国）
• Ligand Pharmaceuticals Incorporated（美国）
• Cyclo Therapeutics, Inc.（美国）
• 淄博千汇生物科技有限公司 (中国)
• 西安德利生化工业股份有限公司 (中国)
• 默克集团（德国）
• Otto Chemie Pvt. Ltd.（印度）
• VIO CHEMICALS（瑞士）
• 阿什兰（美国）
• TCI Chemicals (India) Pvt. Ltd.（日本）

SKU-55855